These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21144987)

  • 1. Pharmacodynamic approaches to optimizing beta-lactam therapy.
    Crandon JL; Nicolau DP
    Crit Care Clin; 2011 Jan; 27(1):77-93. PubMed ID: 21144987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
    Ludwig E; Konkoly-Thege M; Kuti JL; Nicolau DP
    Int J Antimicrob Agents; 2006 Nov; 28(5):433-8. PubMed ID: 17046212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing bactericidal exposure for beta-lactams using prolonged and continuous infusions in the pediatric population.
    Courter JD; Kuti JL; Girotto JE; Nicolau DP
    Pediatr Blood Cancer; 2009 Sep; 53(3):379-85. PubMed ID: 19422028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged infusions of β-lactam antibiotics: implication for antimicrobial stewardship.
    George JM; Towne TG; Rodvold KA
    Pharmacotherapy; 2012 Aug; 32(8):707-21. PubMed ID: 23307519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonging β-lactam infusion: a review of the rationale and evidence, and guidance for implementation.
    MacVane SH; Kuti JL; Nicolau DP
    Int J Antimicrob Agents; 2014 Feb; 43(2):105-13. PubMed ID: 24359838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting Beta-lactams - PK/PD improves dosing of old antibiotics.
    MacGowan A
    Curr Opin Pharmacol; 2011 Oct; 11(5):470-6. PubMed ID: 21862409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of pharmacodynamic principles to inform β-lactam dosing: "S" does not always mean success.
    Lodise TP; Butterfield J
    J Hosp Med; 2011 Jan; 6 Suppl 1():S16-23. PubMed ID: 21225946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists.
    Lodise TP; Lomaestro BM; Drusano GL;
    Pharmacotherapy; 2006 Sep; 26(9):1320-32. PubMed ID: 16945055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged β-lactam infusion for Gram-negative Infections.
    Tamma PD; Jenh AM; Milstone AM
    Pediatr Infect Dis J; 2011 Apr; 30(4):336-7. PubMed ID: 21407037
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics.
    Mohd Hafiz AA; Staatz CE; Kirkpatrick CM; Lipman J; Roberts JA
    Minerva Anestesiol; 2012 Jan; 78(1):94-104. PubMed ID: 21730935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing use of beta-lactam antibiotics in the critically ill.
    Roberts JA; Lipman J
    Semin Respir Crit Care Med; 2007 Dec; 28(6):579-85. PubMed ID: 18095221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem.
    Kuti JL; Dandekar PK; Nightingale CH; Nicolau DP
    J Clin Pharmacol; 2003 Oct; 43(10):1116-23. PubMed ID: 14517194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/pharmacodynamic evaluation of anti-infective agents.
    Schuck EL; Derendorf H
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):361-73. PubMed ID: 15954853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation.
    Lomaestro BM; Drusano GL
    Antimicrob Agents Chemother; 2005 Jan; 49(1):461-3. PubMed ID: 15616337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
    Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Nicolau DP; Shore E; Palter M; Pepe J; Kuti JL
    J Crit Care; 2010 Mar; 25(1):69-77. PubMed ID: 19427167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous and extended infusions of β-lactam antibiotics in the pediatric population.
    Walker MC; Lam WM; Manasco KB
    Ann Pharmacother; 2012 Nov; 46(11):1537-46. PubMed ID: 23115223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous infusion of beta-lactams.
    Mouton JW; Vinks AA
    Curr Opin Crit Care; 2007 Oct; 13(5):598-606. PubMed ID: 17762242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Part II. Introduction to the beta-lactam antibiotics.
    Cooper TW; Gibbs WJ; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2006 Oct; 99(10):516-20. PubMed ID: 17125105
    [No Abstract]   [Full Text] [Related]  

  • 20. Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia.
    Kim A; Kuti JL; Nicolau DP
    Clin Ther; 2009 Nov; 31(11):2765-78. PubMed ID: 20110018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.